MEDTECH SOLUTIONS
Asia- Pacific region is a hotspot for medical devices. Advancing technologies, aging populations, growing economies and increasing health care spending by individuals and governments, offer vast growth for multinational and local medical device companies.
The region is diverse, and each country presents a complex and challenging regulatory landscape. Gaining market access to Asia Pacific requires a deep understanding of the regulations, culture and payer expectations. Development and commercialization strategies must be aligned with regulatory and market demands, coupled with collaborative relationships with payers, providers and vendors.
IQVIA offers an integrated solution for medical device and diagnostics companies to:
Navigate complex regulatory environment
Optimize medical device clinical development
Accelerate market approvals
Develop strategies for better commercial performance
OUR SOLUTIONS
Regulatory Services
Clinical Trials
Preferred provider by the world’s largest medical device companies
Accelerate timelines and chart a precise path via our optimized clinical trial management processes
Consulting Services
Market Analytics
Therapeutic Expertise
Diagnostics
THOUGHT LEADERSHIP
Winning with innovation
The Asia-Pacific region (APAC) is now the fastest growing medical device region in the world, and is expected to outgrow Europe to become the second largest medical technology (Medtech) market by 2020. This trend is being driven by demographic changes, economic growth and a maturing healthcare landscape.
In this paper, we explore different forms of innovation that are emerging within the APAC medical device market and the evolving roles that both LCGAs and MNCs are carving out for themselves. We will outline opportunities and challenges for players looking to win in this space.